<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel>
  <title>Charles River Laboratories — fllwup^</title>
  <link>https://fllwup.co/topic/charles-river-laboratories/</link>
  <description>Track Charles River Laboratories news in real time — S&amp;P 500 — drug research services, CRL. fllwup^ collects the latest Charles River Laboratories headlines from every major source into one live feed — free, no account, no algorithm.</description>
  <lastBuildDate>Sun, 22 Nov 2026 10:07:48 GMT</lastBuildDate>
  <item><title>Charles River Laboratories International (CRL) Recovers Following Cyclical Contraction</title><link>https://news.google.com/rss/articles/CBMiqAFBVV95cUxNcF9iXzF5VGFHQnVnRUFmRnhsN2M5U0UyTlhxM0prb0FhMUNyWklNVF9PaEd5Z0NCVE55X3poX3lUV3V0NWduVzNOdEtIcU1EcFhLa1BmbnZYcmV2ZnBmYTJad2Y3bjBTcE9QZG1ueEVEeUFBbnRiQVdDd1h0RXJfV3diMmk1LTQ0S3pyNzRUSkJxSU83RTZGVXZPNXZLUkFwWFVycGlrRTI?oc=5</link><source url="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNcF9iXzF5VGFHQnVnRUFmRnhsN2M5U0UyTlhxM0prb0FhMUNyWklNVF9PaEd5Z0NCVE55X3poX3lUV3V0NWduVzNOdEtIcU1EcFhLa1BmbnZYcmV2ZnBmYTJad2Y3bjBTcE9QZG1ueEVEeUFBbnRiQVdDd1h0RXJfV3diMmk1LTQ0S3pyNzRUSkJxSU83RTZGVXZPNXZLUkFwWFVycGlrRTI?oc=5">Yahoo Finance</source></item>
  <item><title>Should You Continue to Hold Charles River Stock in Your Portfolio?</title><link>https://news.google.com/rss/articles/CBMivgFBVV95cUxPcEl6ZEROZl8tRHI0MW1CTE0zcERXSGRHVjdVUF9BVkE1OThNYURNU2V5NzdabUg0aENsMHR6UmExYjhZb3p6bVBHQmFGX3RlWi14bGc1Mzc0Sl9ZOVh6NU10TURJQWZCU3pFcm5tTnRXTGZ6LWZVQlFpSjlZUVVuN0hKaGxJSklWMTNpVlV2WnpSYUlBMExLRXF0MG1wd1NIMG14TEZjM1VIOE5ycFB2NHZOaDBkb2FELVg2WUVn?oc=5</link><source url="https://news.google.com/rss/articles/CBMivgFBVV95cUxPcEl6ZEROZl8tRHI0MW1CTE0zcERXSGRHVjdVUF9BVkE1OThNYURNU2V5NzdabUg0aENsMHR6UmExYjhZb3p6bVBHQmFGX3RlWi14bGc1Mzc0Sl9ZOVh6NU10TURJQWZCU3pFcm5tTnRXTGZ6LWZVQlFpSjlZUVVuN0hKaGxJSklWMTNpVlV2WnpSYUlBMExLRXF0MG1wd1NIMG14TEZjM1VIOE5ycFB2NHZOaDBkb2FELVg2WUVn?oc=5">TradingView</source></item>
  <item><title>Charles River Laboratories (CRL) Stock Looks Fairly Valued Despite Its 106% Run</title><link>https://news.google.com/rss/articles/CBMiowFBVV95cUxQbloxVlVjcnM3NEJPTDVMZjFtd3FMNDB4WG5HTjZqNldEa3NyTFBlU3JGdUhYd3ZfMUg0OXR3YjZYNmNZUnp0OHV4aXBpYm5Oa0lhSlotOV9hMVNiY0Fac0pnUUJhTFFiS3ZFeHZkR2NnTmZKb1J0VE5idVRSTXM0QUlkcUgxSHNIWlBmVndKQ1owb0xyMjdxTzdMOHRya1Q1RElF?oc=5</link><source url="https://news.google.com/rss/articles/CBMiowFBVV95cUxQbloxVlVjcnM3NEJPTDVMZjFtd3FMNDB4WG5HTjZqNldEa3NyTFBlU3JGdUhYd3ZfMUg0OXR3YjZYNmNZUnp0OHV4aXBpYm5Oa0lhSlotOV9hMVNiY0Fac0pnUUJhTFFiS3ZFeHZkR2NnTmZKb1J0VE5idVRSTXM0QUlkcUgxSHNIWlBmVndKQ1owb0xyMjdxTzdMOHRya1Q1RElF?oc=5">Yahoo Finance</source></item>
  <item><title>Charles River Laboratories (NYSE:CRL) Share Price, Forecast &amp; Analysis</title><link>https://news.google.com/rss/articles/CBMicEFVX3lxTFBldF9FR2VmQVl0ODI1Q29MUV9RRHd1OEkzWHAwR0FWVFlMeFdWV2ZMOE0zNEZNTkhidldiZnlmSlRqLTlOcHh3ZEFNSXp5cDIwTEgzcHRLanJSVlRvRjR4ejNwYVI2ZzBMajVEd2tfSXg?oc=5</link><source url="https://news.google.com/rss/articles/CBMicEFVX3lxTFBldF9FR2VmQVl0ODI1Q29MUV9RRHd1OEkzWHAwR0FWVFlMeFdWV2ZMOE0zNEZNTkhidldiZnlmSlRqLTlOcHh3ZEFNSXp5cDIwTEgzcHRLanJSVlRvRjR4ejNwYVI2ZzBMajVEd2tfSXg?oc=5">Stocks Down Under</source></item>
  <item><title>Charles River Laboratories International Inc. stock outperforms competitors on strong trading day</title><link>https://news.google.com/rss/articles/CBMi7AFBVV95cUxOQlgwV1NReDMxeDNZcTU5X005LUlNQnFUNHVEbld0d0pvc0RXUG5yNXpldjREbUhxblNCNmpMaXJ1cHpFOVpwYnNORVJfeFVYZW96M1lsbDR5S0E4d1VGX2xZMFRkdFNUUnBUNDNOOXZTOHpiY0h5eVNqcDZIZ2hianA1Wnk1ZlpQYmJNeTgydkh6aUdjNjFDYjR4dXZsUkVzdVh2ck5KYURsbVUxUk05cDQ2ejh6NVh3NGlfU0ZUTV84X2tFcGcwek5ZSWEyZW9JWlZ3bHFhT3pSZjlKN092VFRKdVdORUZnUGlGVw?oc=5</link><source url="https://news.google.com/rss/articles/CBMi7AFBVV95cUxOQlgwV1NReDMxeDNZcTU5X005LUlNQnFUNHVEbld0d0pvc0RXUG5yNXpldjREbUhxblNCNmpMaXJ1cHpFOVpwYnNORVJfeFVYZW96M1lsbDR5S0E4d1VGX2xZMFRkdFNUUnBUNDNOOXZTOHpiY0h5eVNqcDZIZ2hianA1Wnk1ZlpQYmJNeTgydkh6aUdjNjFDYjR4dXZsUkVzdVh2ck5KYURsbVUxUk05cDQ2ejh6NVh3NGlfU0ZUTV84X2tFcGcwek5ZSWEyZW9JWlZ3bHFhT3pSZjlKN092VFRKdVdORUZnUGlGVw?oc=5">MarketWatch</source></item>
  <item><title>Medtech Player Hits A Key Four-Year High; Shares Surge</title><link>https://news.google.com/rss/articles/CBMiuwFBVV95cUxNNkpPLVU3bFdWWmtmSVgtVzdEOWZwZm5rUjdiUE15OUJlVGxMTDduX3gwOFhaUVBYS0pTeHp0Tzhhb0lReUxHX1EzUXRvLXdZQ0ttRjdBQ0VTdXNGQVoweERWeGdsaDRIbEFLcmZxUEstOFA5T1VoUjYtTk1WMXpobHk5UXJkb1U3U0ZoQmp3TzdhUEh5OG4zSXg4SklIM0cydnY5MmJvdDFZUnFvYmFQM1o1Ny1kZzAtdks4?oc=5</link><source url="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNNkpPLVU3bFdWWmtmSVgtVzdEOWZwZm5rUjdiUE15OUJlVGxMTDduX3gwOFhaUVBYS0pTeHp0Tzhhb0lReUxHX1EzUXRvLXdZQ0ttRjdBQ0VTdXNGQVoweERWeGdsaDRIbEFLcmZxUEstOFA5T1VoUjYtTk1WMXpobHk5UXJkb1U3U0ZoQmp3TzdhUEh5OG4zSXg4SklIM0cydnY5MmJvdDFZUnFvYmFQM1o1Ny1kZzAtdks4?oc=5">Investor's Business Daily</source></item>
  <item><title>Charles River rises on Investor Day on promising 2026 outlook</title><link>https://news.google.com/rss/articles/CBMijwFBVV95cUxPSUVTeHNESFhWbkdRSVdUbGpUeWkyVk5XaEUwSlJHZ2ZEV2x5Vm5xcmZPbzd5MGpRS3ZTbXdOWHZKRTAtcDFMTjB2R01wNXZzNkRGMmtnZFppUEhpWHR3a3VfYWF6elB6QXJWNlZrZlM2b0ZYZ0M0VmtMRDZzRXNadHF5WjYzR2F3MTk0bU9HSQ?oc=5</link><source url="https://news.google.com/rss/articles/CBMijwFBVV95cUxPSUVTeHNESFhWbkdRSVdUbGpUeWkyVk5XaEUwSlJHZ2ZEV2x5Vm5xcmZPbzd5MGpRS3ZTbXdOWHZKRTAtcDFMTjB2R01wNXZzNkRGMmtnZFppUEhpWHR3a3VfYWF6elB6QXJWNlZrZlM2b0ZYZ0M0VmtMRDZzRXNadHF5WjYzR2F3MTk0bU9HSQ?oc=5">Seeking Alpha</source></item>
  <item><title>Why Charles River Laboratories (CRL) Stock Is Up Today</title><link>https://news.google.com/rss/articles/CBMioAFBVV95cUxQZDlVcG05RHBPa3JCckdzX1Q3WVdmN3NwN2YxVVRNNGRKNURuNWxBaU15R2p4LU5ld0UyT2Y4QmNHZlZ1ZldHTktsZjdTMUcyZDYwR1Z6VUVEQ2V3MkFETzVDaXVzWWNCYzVKM2NMMm9uMFhxeUVSSFg0QzVNanRKTy1SMEEwM3BnOU5NLS15LTlXaUxJM0lVQlpUVWpYTDFQ?oc=5</link><source url="https://news.google.com/rss/articles/CBMioAFBVV95cUxQZDlVcG05RHBPa3JCckdzX1Q3WVdmN3NwN2YxVVRNNGRKNURuNWxBaU15R2p4LU5ld0UyT2Y4QmNHZlZ1ZldHTktsZjdTMUcyZDYwR1Z6VUVEQ2V3MkFETzVDaXVzWWNCYzVKM2NMMm9uMFhxeUVSSFg0QzVNanRKTy1SMEEwM3BnOU5NLS15LTlXaUxJM0lVQlpUVWpYTDFQ?oc=5">Yahoo Finance</source></item>
  <item><title>Charles River (CRL) Stock Could Be 27% Overvalued As Preclinical FDA Collaboration Starts</title><link>https://news.google.com/rss/articles/CBMimgFBVV95cUxNaFgtcFVmRkp3VVlaVVVuQXdxbGpGUGZYX3l2bTRRQUVIalFYbFpFNWpWWExGWHQ0WnIwS3hkRUp5OGZMemdyTUNqREV2TDRKaW8xZVFsMlNGMXFvUEFCTHpIUERVX2owZ0xFZlVBR1B0Y3pYUW93Z0V3OXZhNjNTWWlvMGljd1hMZDZ3TXhjRFFJWFhRZ3oxUTVR?oc=5</link><source url="https://news.google.com/rss/articles/CBMimgFBVV95cUxNaFgtcFVmRkp3VVlaVVVuQXdxbGpGUGZYX3l2bTRRQUVIalFYbFpFNWpWWExGWHQ0WnIwS3hkRUp5OGZMemdyTUNqREV2TDRKaW8xZVFsMlNGMXFvUEFCTHpIUERVX2owZ0xFZlVBR1B0Y3pYUW93Z0V3OXZhNjNTWWlvMGljd1hMZDZ3TXhjRFFJWFhRZ3oxUTVR?oc=5">Yahoo Finance</source></item>
  <item><title>Will Earnings Beat Change Charles River Laboratories' (CRL) Narrative</title><link>https://news.google.com/rss/articles/CBMioAFBVV95cUxNUS1YRUU1NW5rbGV4NTRKMEtfd0ZZNTVaSmNvbkxucVBuX1Rmc3QxWk9vaVVvRWdtOHNDQ0h6aXRKdHJJNGpyaHJSVkhiazR5MXdnNXIwU1Bhbl9BRXFlZU1PMXdrYVFzMVFybDNsQ0o1bFE5Vl9TQXcza1FmOFBVSllLa3F6U1pwdmFpWU5MQndGS3ZLSzUyT19TTlZhM005?oc=5</link><source url="https://news.google.com/rss/articles/CBMioAFBVV95cUxNUS1YRUU1NW5rbGV4NTRKMEtfd0ZZNTVaSmNvbkxucVBuX1Rmc3QxWk9vaVVvRWdtOHNDQ0h6aXRKdHJJNGpyaHJSVkhiazR5MXdnNXIwU1Bhbl9BRXFlZU1PMXdrYVFzMVFybDNsQ0o1bFE5Vl9TQXcza1FmOFBVSllLa3F6U1pwdmFpWU5MQndGS3ZLSzUyT19TTlZhM005?oc=5">Yahoo Finance</source></item>
</channel></rss>